Clinical Trials Directory

Trials / Unknown

UnknownNCT05097183

Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation

Clinical Validation and Prognostic Evaluation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation

Status
Unknown
Phase
Study type
Observational
Enrollment
274 (estimated)
Sponsor
Ignacio J. Amat Santos · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Background: Transcatheter aortic valve replacement (TAVR) has become the preferred therapy for aortic stenosis. Given the growing life-expectancy, the risk of requiring coronary interventions or of developing prosthesis degeneration that could require TAVR-in-TAVR for its treatment progressively increases. During standard TAVI procedures the native and the prosthesis commissures are randomly aligned with misalignment in up to 70% of the cases. This might hinder coronary re-access in 18% of the cases, increase the risk of coronary obstruction during future TAVR-in-TAVR procedures, and has been associated to greater residual gradients. Methods: Although several techniques have been developed to increase the degree of commissural alignment, all are imperfect or imply manipulation of the system within the patient, potentially increasing the risk of complications. The research team developed a software based on computed tomography analysis that allows planification of accurate commissural alignment by inserting the delivery system in a patient-specific degree of rotation. Aim: The proponent team aimed to prospectively validate this methodology comparing a cohort of patients harboring TAVR with Acurate Commissural Alignment (ACA) vs. a control cohort with non-ACA standard technique, in order to determine benefits in terms of coronary re-access and clinical events (coronary events, valve degeneration, and TAVR-in-TAVR).

Conditions

Interventions

TypeNameDescription
PROCEDUREAccurate Commissural Alignment (ACA)Software based, computed tomography analysis that allows planification of accurate commissural alignment of TAVR by inserting the delivery system in a patient-specific degree of rotation.

Timeline

Start date
2021-12-01
Primary completion
2023-12-31
Completion
2024-12-31
First posted
2021-10-28
Last updated
2022-04-20

Locations

15 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT05097183. Inclusion in this directory is not an endorsement.